Strategic investment boosts amsight’s traceability tech for regulated AM sectors
amsight GmbH, based in Hamburg, Germany, has gained a strategic investor in Butterfly & Elephant, the investment company of GS1 Germany. This investment, part of a Pre-Seed II financing round, is intended to strengthen amsight’s role as a technological enabler for quality-assured Additive Manufacturing.
Together, the companies aim to advance end-to-end traceability of additively manufactured parts as well as the exchange of digital product and process data based on GS1 standards, particularly in highly regulated industries such as medical technology, defence, aerospace, and aviation.
The investment is intended to actively support the digitalisation, standardisation, and automation of AM through the development of solutions that enable companies to transparently document and securely exchange quality-critical parameters across the entire production chain.
Article: Inside Nikon’s metal AM strategy
Part 2: Scaling industrial production in Long Beach
| Read now |
“We are very pleased to have gained Butterfly & Elephant as an investor who not only provides capital, but above all brings deep strategic expertise in standardisation as well as part identification and labelling,” said Dr-Ing Tim Wischeropp, CEO & Co-Founder of amsight GmbH. “Together, we will elevate the exchange of digital manufacturing data and traceability in industrial 3D printing to a new level.”
The new capital will be used to accelerate product development, further expand the software, particularly in the areas of data standardisation and compliance, and to drive market entry in highly regulated industries.
Benjamin Birker, Managing Director of Butterfly & Elephant, shared, “amsight addresses a central lever of industrial Additive Manufacturing: transparency and trust through data. We see tremendous potential in jointly establishing GS1 standards for digital process quality in regulated markets.”
www.amsight.de
